Maximus, Inc. (MMS) Director Raymond B. Ruddy Sells 25,000 Shares of Stock

Maximus, Inc. (NYSE:MMS) Director Raymond B. Ruddy sold 25,000 shares of Maximus stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $62.68, for a total transaction of $1,567,000.00. Following the transaction, the director now directly owns 227,552 shares of the company’s stock, valued at $14,262,959.36. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Shares of Maximus, Inc. (NYSE MMS) opened at 63.51 on Wednesday. Maximus, Inc. has a 1-year low of $43.69 and a 1-year high of $64.97. The company has a 50-day moving average of $60.45 and a 200-day moving average of $61.38. The firm has a market cap of $4.12 billion, a PE ratio of 20.36 and a beta of 1.37.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.03. The firm had revenue of $600.40 million during the quarter, compared to analysts’ expectations of $614.12 million. Maximus had a return on equity of 25.08% and a net margin of 8.43%. Maximus’s revenue was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.79 earnings per share. Analysts predict that Maximus, Inc. will post $3.13 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 31st. Shareholders of record on Tuesday, August 15th were given a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 0.28%. The ex-dividend date was Friday, August 11th. Maximus’s payout ratio is 5.73%.

COPYRIGHT VIOLATION WARNING: This story was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at https://sportsperspectives.com/2017/09/13/maximus-inc-mms-director-raymond-b-ruddy-sells-25000-shares-of-stock.html.

A number of research firms recently issued reports on MMS. BidaskClub cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, July 13th. Maxim Group set a $66.00 price target on shares of Maximus and gave the company a “hold” rating in a research note on Thursday, August 3rd. ValuEngine cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. KeyCorp reissued a “sector weight” rating on shares of Maximus in a research note on Thursday, May 25th. Finally, Zacks Investment Research raised shares of Maximus from a “sell” rating to a “hold” rating in a research note on Wednesday, July 26th. One equities research analyst has rated the stock with a sell rating and nine have given a hold rating to the stock. The stock has an average rating of “Hold” and an average price target of $62.43.

Large investors have recently added to or reduced their stakes in the business. Van Berkom & Associates Inc. raised its position in Maximus by 4.5% in the second quarter. Van Berkom & Associates Inc. now owns 1,150,713 shares of the health services provider’s stock worth $72,069,000 after acquiring an additional 49,360 shares in the last quarter. American International Group Inc. raised its position in Maximus by 4.1% in the first quarter. American International Group Inc. now owns 166,652 shares of the health services provider’s stock worth $10,366,000 after acquiring an additional 6,634 shares in the last quarter. Geode Capital Management LLC raised its position in Maximus by 6.9% in the first quarter. Geode Capital Management LLC now owns 496,870 shares of the health services provider’s stock worth $30,905,000 after acquiring an additional 31,918 shares in the last quarter. OppenheimerFunds Inc. raised its position in Maximus by 19.5% in the first quarter. OppenheimerFunds Inc. now owns 11,010 shares of the health services provider’s stock worth $685,000 after acquiring an additional 1,793 shares in the last quarter. Finally, Advantus Capital Management Inc raised its position in Maximus by 3.1% in the first quarter. Advantus Capital Management Inc now owns 8,298 shares of the health services provider’s stock worth $516,000 after acquiring an additional 248 shares in the last quarter. Hedge funds and other institutional investors own 97.23% of the company’s stock.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply